- Report
- June 2025
- 400 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Report
- July 2024
- 185 Pages
Global
From €3357EUR$3,825USD£2,905GBP
€3949EUR$4,500USD£3,417GBP
- Report
- December 2024
- 150 Pages
Global
From €2852EUR$3,250USD£2,468GBP
€4256EUR$4,850USD£3,683GBP
- Report
- December 2022
- 93 Pages
Global
From €4827EUR$5,500USD£4,176GBP
- Report
- April 2019
- 153 Pages
Global
From €2413EUR$2,750USD£2,088GBP
- Report
- January 2020
- 30 Pages
China
From €1931EUR$2,200USD£1,671GBP
- Report
- February 2023
- 120 Pages
North America
From €2185EUR$2,490USD£1,891GBP
- Report
- October 2023
- 90 Pages
Malaysia
From €2611EUR$2,975USD£2,259GBP
€3072EUR$3,500USD£2,658GBP
- Report
- August 2023
- 74 Pages
Egypt
From €2611EUR$2,975USD£2,259GBP
€3072EUR$3,500USD£2,658GBP
- Report
- November 2023
- 80 Pages
Germany
From €2611EUR$2,975USD£2,259GBP
€3072EUR$3,500USD£2,658GBP
- Report
- February 2024
- 180 Pages
Global
From €4361EUR$4,969USD£3,773GBP
- Report
- April 2023
- 114 Pages
Global
From €4169EUR$4,750USD£3,607GBP
- Report
- October 2023
- 177 Pages
Global
From €3357EUR$3,825USD£2,905GBP
€3949EUR$4,500USD£3,417GBP
- Report
- January 2024
- 171 Pages
Global
From €2194EUR$2,500USD£1,898GBP
- Report
- April 2024
- 120 Pages
Global
From €2984EUR$3,400USD£2,582GBP
€3730EUR$4,250USD£3,227GBP
- Report
- April 2023
- 114 Pages
Global
From €4169EUR$4,750USD£3,607GBP
- Report
- October 2023
- 145 Pages
Global
From €2764EUR$3,150USD£2,392GBP
- Report
- January 2024
- 150 Pages
Global
From €2852EUR$3,250USD£2,468GBP
€4256EUR$4,850USD£3,683GBP
- Report
- April 2023
- 147 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Report
- August 2023
- 116 Pages
Global
From €3949EUR$4,500USD£3,417GBP
The Kidney Transplant market is a subset of the biotechnology industry that focuses on the development of treatments and technologies related to kidney transplantation. This includes the development of new drugs, medical devices, and surgical techniques to improve the safety and efficacy of kidney transplantation. Additionally, the market includes research into the development of new immunosuppressive drugs to reduce the risk of organ rejection.
The Kidney Transplant market is highly competitive, with many companies vying for a share of the market. Companies in the market include Astellas Pharma, Novartis, Roche, Merck, and Pfizer. Additionally, there are a number of smaller companies that specialize in the development of new treatments and technologies related to kidney transplantation. Show Less Read more
